Evidence map›Paper›PMID 24949938›Full record

ArticleDevelopmental biology2014

Multiple tissue-specific requirements for the BMP antagonist Noggin in development of the mammalian craniofacial skeleton.

Maiko Matsui, John Klingensmith

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Genetic architecture of craniofacial morphogenesis: roles ofFrontiers in cell and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evolutionary mechanisms modulating the mammalian skull development.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Regulatory mechanisms of jaw bone and tooth development.Current topics in developmental biology · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maiko MatsuiDepartment of Cell Biology, Duke University Medical Center, Durham NC27710, USA. Electronic address: maiko.matsui@gmail.com.
John KlingensmithDepartment of Cell Biology, Duke University Medical Center, Durham NC27710, USA. Electronic address: john.klingensmith@duke.edu.
Duke University · US

Funding

ROLES OF CHORDIN AND NOGGIN IN CRANIOFACIAL DEVELOPMENTR01DE013674 · NIDCR · DUKE UNIVERSITY · PI KLINGENSMITH, JOHN A · 2001 to 2006
$2.1M
Role of BMP Antagonism in Craniofacial and Foregut DevelopmentR56DE013674 · NIDCR · DUKE UNIVERSITY · PI KLINGENSMITH, JOHN A · 2008 to 2010
$438k
NIDCR NIH HHS R01 DE013674NIDCR NIH HHS R56 DE013674
6 · The paper itself

Abstract

Proper morphogenesis is essential for both form and function of the mammalian craniofacial skeleton, which consists of more than twenty small cartilages and bones. Skeletal elements that support the oral cavity are derived from cranial neural crest cells (NCCs) that develop in the maxillary and mandibular buds of pharyngeal arch 1 (PA1). Bone Morphogenetic Protein (BMP) signaling has been implicated in most aspects of craniofacial skeletogenesis, including PA1 development. However, the roles of the BMP antagonist Noggin in formation of the craniofacial skeleton remain unclear, in part because of its multiple domains of expression during formative stages. Here we used a tissue-specific gene ablation approach to assess roles of Noggin (Nog) in two different tissue domains potentially relevant to mandibular and maxillary development. We found that the axial midline domain of Nog expression is critical to promote PA1 development in early stages, necessary for adequate outgrowth of the mandibular bud. Subsequently, Nog expression in NCCs regulates craniofacial cartilage and bone formation. Mice lacking Nog in NCCs have an enlarged mandible that results from increased cell proliferation in and around Meckel׳s cartilage. These mutants also show complete secondary cleft palate, most likely due to inhibition of posterior palatal shelf elevation by disrupted morphology of the developing skull base. Our findings demonstrate multiple roles of Noggin in different domains for craniofacial skeletogenesis, and suggest an indirect mechanism for secondary cleft palate in Nog mutants that may be relevant to human cleft palate as well.

Indexed as

AnimalsBone Morphogenetic ProteinsBranchial RegionCarrier ProteinsCell MovementCell ProliferationCleft PalateGalactosidesGlycoproteinsHumansImmunohistochemistryIndolesIn Situ HybridizationIntercellular Signaling Peptides and ProteinsMiceNeural Crest5-bromo-4-chloro-3-indolyl beta-galactosideBone Morphogenetic ProteinsCarrier ProteinschordinGalactosidesGlycoproteinsIndolesIntercellular Signaling Peptides and ProteinsNoggin ProteinBone morphogenetic proteinMandibleMouse developmentNeural crestNogginPalate

Identifiers

PMID24949938
PMCPMC4399715
OpenAlexW1968475705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.